A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

Overview of attention for article published in Molecular Autism, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 3 news outlets
twitter: 16 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 75 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Large Trial Finds Oxytocin Nasal Spray Is Ineffective for Autism

True Viral News, 14 Oct 2021

According to the largest clinical trial to date, an intranasal version of the hormone oxytocin was no more effective than…

Large Trial Finds Oxytocin Nasal Spray Is Ineffective for Autism

Scientific American, 14 Oct 2021

An intranasal form of the hormone oxytocin is no more effective than placebo at increasing social behaviors in autistic children…

Intranasal oxytocin ineffective for autism in large trial | Spectrum | Autism Research News

Spectrum News, 13 Oct 2021

Placebo effect: Intranasal oxytocin is unlikely to increase sociability in most autistic children, according to a new study.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.